Swiss National Bank’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-116,200
| Closed | -$591K | – | 2729 |
|
|
2021
Q3 | $591K | Hold |
116,200
| – | – | ﹤0.01% | 2563 |
|
|
2021
Q2 | $736K | Hold |
116,200
| – | – | ﹤0.01% | 2566 |
|
|
2021
Q1 | $898K | Buy |
116,200
+22,200
| +24% | +$172K | ﹤0.01% | 2373 |
|
|
2020
Q4 | $616K | Buy |
94,000
+2,700
| +3% | +$17.7K | ﹤0.01% | 2432 |
|
|
2020
Q3 | $607K | Hold |
91,300
| – | – | ﹤0.01% | 2317 |
|
|
2020
Q2 | $761K | Buy |
91,300
+4,400
| +5% | +$36.7K | ﹤0.01% | 2251 |
|
|
2020
Q1 | $667K | Hold |
86,900
| – | – | ﹤0.01% | 2041 |
|
|
2019
Q4 | $722K | Buy |
86,900
+3,000
| +4% | +$24.9K | ﹤0.01% | 2292 |
|
|
2019
Q3 | $619K | Hold |
83,900
| – | – | ﹤0.01% | 2282 |
|
|
2019
Q2 | $941K | Buy |
83,900
+6,000
| +8% | +$67.3K | ﹤0.01% | 2148 |
|
|
2019
Q1 | $837K | Buy |
77,900
+2,400
| +3% | +$25.8K | ﹤0.01% | 2166 |
|
|
2018
Q4 | $1.14M | Buy |
75,500
+2,700
| +4% | +$40.8K | ﹤0.01% | 1926 |
|
|
2018
Q3 | $1.35M | Buy |
72,800
+12,600
| +21% | +$233K | ﹤0.01% | 1973 |
|
|
2018
Q2 | $1.38M | Buy |
60,200
+24,600
| +69% | +$562K | ﹤0.01% | 1965 |
|
|
2018
Q1 | $1.01M | Buy |
35,600
+2,200
| +7% | +$62.6K | ﹤0.01% | 2071 |
|
|
2017
Q4 | $705K | Hold |
33,400
| – | – | ﹤0.01% | 2287 |
|
|
2017
Q3 | $607K | Hold |
33,400
| – | – | ﹤0.01% | 2312 |
|
|
2017
Q2 | $518K | Buy |
33,400
+6,600
| +25% | +$102K | ﹤0.01% | 2392 |
|
|
2017
Q1 | $463K | Buy |
26,800
+4,300
| +19% | +$74.3K | ﹤0.01% | 2402 |
|
|
2016
Q4 | $247K | Hold |
22,500
| – | – | ﹤0.01% | 2533 |
|
|
2016
Q3 | $353K | Hold |
22,500
| – | – | ﹤0.01% | 2445 |
|
|
2016
Q2 | $230K | Buy |
+22,500
| New | +$230K | ﹤0.01% | 2550 |
|